206 related articles for article (PubMed ID: 23236148)
1. Production of unique immunotoxin cancer therapeutics in algal chloroplasts.
Tran M; Van C; Barrera DJ; Pettersson PL; Peinado CD; Bui J; Mayfield SP
Proc Natl Acad Sci U S A; 2013 Jan; 110(1):E15-22. PubMed ID: 23236148
[TBL] [Abstract][Full Text] [Related]
2. Production of anti-cancer immunotoxins in algae: ribosome inactivating proteins as fusion partners.
Tran M; Henry RE; Siefker D; Van C; Newkirk G; Kim J; Bui J; Mayfield SP
Biotechnol Bioeng; 2013 Nov; 110(11):2826-35. PubMed ID: 23719862
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and assembly of a full-length human monoclonal antibody in algal chloroplasts.
Tran M; Zhou B; Pettersson PL; Gonzalez MJ; Mayfield SP
Biotechnol Bioeng; 2009 Nov; 104(4):663-73. PubMed ID: 19562731
[TBL] [Abstract][Full Text] [Related]
4. The algal chloroplast as a synthetic biology platform for production of therapeutic proteins.
Dyo YM; Purton S
Microbiology (Reading); 2018 Feb; 164(2):113-121. PubMed ID: 29297850
[TBL] [Abstract][Full Text] [Related]
5. Accumulation and processing of a recombinant protein designed as a cleavable fusion to the endogenous Rubisco LSU protein in Chlamydomonas chloroplast.
Muto M; Henry RE; Mayfield SP
BMC Biotechnol; 2009 Mar; 9():26. PubMed ID: 19323825
[TBL] [Abstract][Full Text] [Related]
6. Production of Recombinant Proteins in the Chloroplast of the Green Alga Chlamydomonas reinhardtii.
Guzmán-Zapata D; Macedo-Osorio KS; Almaraz-Delgado AL; Durán-Figueroa N; Badillo-Corona JA
Methods Mol Biol; 2016; 1385():69-85. PubMed ID: 26614282
[TBL] [Abstract][Full Text] [Related]
7. Green biologics: The algal chloroplast as a platform for making biopharmaceuticals.
Taunt HN; Stoffels L; Purton S
Bioengineered; 2018 Jan; 9(1):48-54. PubMed ID: 28892417
[TBL] [Abstract][Full Text] [Related]
8. A novel expression platform for the production of diabetes-associated autoantigen human glutamic acid decarboxylase (hGAD65).
Wang X; Brandsma M; Tremblay R; Maxwell D; Jevnikar AM; Huner N; Ma S
BMC Biotechnol; 2008 Nov; 8():87. PubMed ID: 19014643
[TBL] [Abstract][Full Text] [Related]
9. Recombinant Protein Production in Microalgae: Emerging Trends.
Ahmad N; Mehmood MA; Malik S
Protein Pept Lett; 2020; 27(2):105-110. PubMed ID: 31622194
[TBL] [Abstract][Full Text] [Related]
10. A rapid, modular and marker-free chloroplast expression system for the green alga Chlamydomonas reinhardtii.
Bertalan I; Munder MC; Weiß C; Kopf J; Fischer D; Johanningmeier U
J Biotechnol; 2015 Feb; 195():60-6. PubMed ID: 25554634
[TBL] [Abstract][Full Text] [Related]
11. Recombination and heterologous expression of allophycocyanin gene in the chloroplast of Chlamydomonas reinhardtii.
Su ZL; Qian KX; Tan CP; Meng CX; Qin S
Acta Biochim Biophys Sin (Shanghai); 2005 Oct; 37(10):709-12. PubMed ID: 16215639
[TBL] [Abstract][Full Text] [Related]
12. Algal chloroplast produced camelid VH H antitoxins are capable of neutralizing botulinum neurotoxin.
Barrera DJ; Rosenberg JN; Chiu JG; Chang YN; Debatis M; Ngoi SM; Chang JT; Shoemaker CB; Oyler GA; Mayfield SP
Plant Biotechnol J; 2015 Jan; 13(1):117-24. PubMed ID: 25229405
[TBL] [Abstract][Full Text] [Related]
13. Foot-and-mouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast.
Sun M; Qian K; Su N; Chang H; Liu J; Shen G
Biotechnol Lett; 2003 Jul; 25(13):1087-92. PubMed ID: 12889819
[TBL] [Abstract][Full Text] [Related]
14. Production of therapeutic proteins in algae, analysis of expression of seven human proteins in the chloroplast of Chlamydomonas reinhardtii.
Rasala BA; Muto M; Lee PA; Jager M; Cardoso RM; Behnke CA; Kirk P; Hokanson CA; Crea R; Mendez M; Mayfield SP
Plant Biotechnol J; 2010 Aug; 8(6):719-33. PubMed ID: 20230484
[TBL] [Abstract][Full Text] [Related]
15. Optimization of recombinant protein expression in the chloroplasts of green algae.
Fletcher SP; Muto M; Mayfield SP
Adv Exp Med Biol; 2007; 616():90-8. PubMed ID: 18161493
[TBL] [Abstract][Full Text] [Related]
16. Outlook in the application of Chlamydomonas reinhardtii chloroplast as a platform for recombinant protein production.
Shamriz S; Ofoghi H
Biotechnol Genet Eng Rev; 2016; 32(1-2):92-106. PubMed ID: 28359189
[TBL] [Abstract][Full Text] [Related]
17. Use of the ptxD gene as a portable selectable marker for chloroplast transformation in Chlamydomonas reinhardtii.
Sandoval-Vargas JM; Jiménez-Clemente LA; Macedo-Osorio KS; Oliver-Salvador MC; Fernández-Linares LC; Durán-Figueroa NV; Badillo-Corona JA
Mol Biotechnol; 2019 Jun; 61(6):461-468. PubMed ID: 30997667
[TBL] [Abstract][Full Text] [Related]
18. A simple, low-cost method for chloroplast transformation of the green alga Chlamydomonas reinhardtii.
Economou C; Wannathong T; Szaub J; Purton S
Methods Mol Biol; 2014; 1132():401-11. PubMed ID: 24599870
[TBL] [Abstract][Full Text] [Related]
19. The microalga Chlamydomonas reinhardtii as a platform for the production of human protein therapeutics.
Rasala BA; Mayfield SP
Bioeng Bugs; 2011; 2(1):50-4. PubMed ID: 21636988
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of bacteriophage lytic proteins against Streptococcus pneumoniae in the chloroplast of Chlamydomonas reinhardtii.
Stoffels L; Taunt HN; Charalambous B; Purton S
Plant Biotechnol J; 2017 Sep; 15(9):1130-1140. PubMed ID: 28160380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
